Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

72 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Risk factors and appropriate therapeutic strategies for thrombotic microangiopathy after allogeneic HSCT.
Matsui H, Arai Y, Imoto H, Mitsuyoshi T, Tamura N, Kondo T, Kanda J, Ishikawa T, Imada K, Ueda Y, Toda Y, Anzai N, Yago K, Nohgawa M, Yonezawa A, Tsunemine H, Itoh M, Yamamoto K, Tsuji M, Moriguchi T, Takaori-Kondo A; Kyoto Stem Cell Transplantation Group (KSCTG). Matsui H, et al. Among authors: nohgawa m. Blood Adv. 2020 Jul 14;4(13):3169-3179. doi: 10.1182/bloodadvances.2020002007. Blood Adv. 2020. PMID: 32658984 Free PMC article.
Principal component analysis uncovers cytomegalovirus-associated NK cell activation in Ph+ leukemia patients treated with dasatinib.
Ishiyama K, Kitawaki T, Sugimoto N, Sozu T, Anzai N, Okada M, Nohgawa M, Hatanaka K, Arima N, Ishikawa T, Tabata S, Onaka T, Oka S, Nakabo Y, Amakawa R, Matsui M, Moriguchi T, Takaori-Kondo A, Kadowaki N. Ishiyama K, et al. Among authors: nohgawa m. Leukemia. 2017 Jan;31(1):203-212. doi: 10.1038/leu.2016.174. Epub 2016 Jun 14. Leukemia. 2017. PMID: 27349810
Interobserver concordance of assessments of dysplasia and blast counts for the diagnosis of patients with cytopenia: From the Japanese central review study.
Matsuda A, Kawabata H, Tohyama K, Maeda T, Araseki K, Hata T, Suzuki T, Kayano H, Shimbo K, Usuki K, Chiba S, Ishikawa T, Arima N, Nohgawa M, Ohta A, Miyazaki Y, Nakao S, Ozawa K, Arai S, Kurokawa M, Mitani K, Takaori-Kondo A; Japanese National Research Group on Idiopathic Bone Marrow Failure Syndromes. Matsuda A, et al. Among authors: nohgawa m. Leuk Res. 2018 Nov;74:137-143. doi: 10.1016/j.leukres.2018.06.003. Epub 2018 Jun 7. Leuk Res. 2018. PMID: 29914726
Serum ferritin levels at diagnosis predict prognosis in patients with low blast count myelodysplastic syndromes.
Kawabata H, Usuki K, Shindo-Ueda M, Kanda J, Tohyama K, Matsuda A, Araseki K, Hata T, Suzuki T, Kayano H, Shimbo K, Chiba S, Ishikawa T, Arima N, Nohgawa M, Miyazaki Y, Kurokawa M, Arai S, Mitani K, Takaori-Kondo A; Japanese National Research Group on Idiopathic Bone Marrow Failure Syndromes. Kawabata H, et al. Among authors: nohgawa m. Int J Hematol. 2019 Nov;110(5):533-542. doi: 10.1007/s12185-019-02710-1. Epub 2019 Jul 29. Int J Hematol. 2019. PMID: 31359362
Outcomes of allogeneic stem cell transplantation for DLBCL: a multi-center study from the Kyoto Stem Cell Transplantation Group.
Izumi K, Kanda J, Nishikori M, Arai Y, Ishikawa T, Yoshioka S, Ueda Y, Maeda T, Yonezawa A, Anzai N, Moriguchi T, Imada K, Akasaka T, Nohgawa M, Itoh M, Aiba A, Tsunemine H, Watanabe M, Kondo T, Takaori-Kondo A. Izumi K, et al. Among authors: nohgawa m. Ann Hematol. 2019 Dec;98(12):2815-2823. doi: 10.1007/s00277-019-03835-3. Epub 2019 Nov 12. Ann Hematol. 2019. PMID: 31713653 Clinical Trial.
Impact of Donor Source on Allogeneic Hematopoietic Stem Cell Transplantation for Mature T Cell and Natural Killer Cell Neoplasms in the Kyoto Stem Cell Transplantation Group.
Watanabe M, Kanda J, Arai Y, Hishizawa M, Nishikori M, Ishikawa T, Imada K, Ueda Y, Akasaka T, Yonezawa A, Nohgawa M, Kitano T, Itoh M, Takeoka T, Moriguchi T, Yago K, Arima N, Anzai N, Watanabe M, Kondo T, Takaori-Kondo A; Kyoto Stem Cell Transplantation Group (KSCTG). Watanabe M, et al. Among authors: nohgawa m. Biol Blood Marrow Transplant. 2020 Dec;26(12):2346-2358. doi: 10.1016/j.bbmt.2020.07.032. Epub 2020 Jul 30. Biol Blood Marrow Transplant. 2020. PMID: 32738500 Free article.
Indication and benefit of upfront hematopoietic stem cell transplantation for T-cell lymphoblastic lymphoma in the era of ALL-type induction therapies.
Morita-Fujita M, Arai Y, Yoshioka S, Ishikawa T, Kanda J, Kondo T, Akasaka T, Ueda Y, Imada K, Moriguchi T, Yago K, Kitano T, Yonezawa A, Nohgawa M, Takaori-Kondo A; Kyoto Stem Cell Transplantation Group (KSCTG). Morita-Fujita M, et al. Among authors: nohgawa m. Sci Rep. 2020 Dec 8;10(1):21418. doi: 10.1038/s41598-020-78334-x. Sci Rep. 2020. PMID: 33293600 Free PMC article.
Establishment of a predictive model for GVHD-free, relapse-free survival after allogeneic HSCT using ensemble learning.
Iwasaki M, Kanda J, Arai Y, Kondo T, Ishikawa T, Ueda Y, Imada K, Akasaka T, Yonezawa A, Yago K, Nohgawa M, Anzai N, Moriguchi T, Kitano T, Itoh M, Arima N, Takeoka T, Watanabe M, Hirata H, Asagoe K, Miyatsuka I, An LM, Miyanishi M, Takaori-Kondo A. Iwasaki M, et al. Among authors: nohgawa m. Blood Adv. 2022 Apr 26;6(8):2618-2627. doi: 10.1182/bloodadvances.2021005800. Blood Adv. 2022. PMID: 34933327 Free PMC article.
72 results